Tracking Medicare news, policy, and coverage changes.
We are moving into an era where we can finally converse with our data. We can ask, “Why are denials spiking in Region X?” or “Show me the safety profile of this cohort,” and receive an answer, not a spreadsheet. The post Answers at the Speed of Thought: Healthcare Analytics in the Era of Agentic AI appeared first on MedCity News .
Read full article →A new study claims to have uncovered how Epstein-Barr virus launches immune responses seen in people with multiple sclerosis.
Read full article →Alzheimer's research is moving in new directions, finding ways to make testing much more accessible, and offering more nuanced results.
Read full article →Sean Kaufman, Trump's pick for a key pandemic preparedness role, has questioned vaccines and criticized the CDC.
Read full article →A trio of bipartisan lawmakers reintroduced a bill requiring the FTC and Treasury to investigate whether the U.S. relies too heavily on foreign countries as part of its pharmaceutical supply…
Read full article →Elevance Health, the country’s second-biggest health insurer, said it plans to further shrink its Medicaid portfolio in the coming year, just as states roll out work requirements.
Read full article →In this AI Prognosis news roundup: Mayo's AI whistleblower, Sutter Health's reply to lawsuit over Abridge scribe, and more.
Read full article →Glenmark Pharmaceuticals agreed to pay $29.6 million to settle price-fixing allegations in a long-running battle with dozens of states.
Read full article →Medicare is proposing to ban vendors from providing remote patient monitoring services on behalf of doctors.
Read full article →FDA's new CBER chief promises normalcy, an weight loss drug without GLP-1s, and more biotech news from The Readout
Read full article →Managing risk factors is the key to further progress in reducing deaths from coronary artery disease, a new study finds.
Read full article →In a survey, 93% of cancer researchers who study disparities said federal policy changes have affected them. Funding is harder to come by and they worry it's slowing progress in their field.
Read full article →